Table 2 Cycle outcomes of ATA-negative and ATA-positive patients
Variable | ATA negative (n = 250) | ATA positive (n = 65) | p |
|---|---|---|---|
Total dose of gonadotropins (IU) | 1910.0 ± 749.7 | 2073.1 ± 754.6 | 0.09 |
Peak estradiol (pg/mL) | 2069.1 ± 1214.0 | 2185 ± 1273.1 | 0.45 |
Serum progesterone (ng/mL) | 0.75 ± 0.52 | 0.69 ± 0.36 | 0.74 |
No. of retrieved oocytes | 8.3 ± 3.9 | 8.5 ± 4.6 | 0.87 |
No. of metaphase 2 oocytes | 5.3 ± 3.2 | 5.6 ± 3.5 | 0.66 |
Fertilization rate (%) | 97.1 ± 10.5 | 91.5 ± 19.8 | 0.003 |
Cleavage rate (%) | 99.9 ± 0.9 | 97.7 ± 13.8 | 0.05 |
Presence of top-quality embryo (%) | 67.8 | 56.5 | 0.09 |
Implantation rate (%) | 50.4 | 50.8 | 0.95 |
Miscarriage rate (%) | 9.6 | 12.7 | 0.47 |